The mean expression level of each tumor-infiltrating immune cell subset was similar in women and men [727.7 vs. 781.7 (CD3+); 353.2 vs. 392.2 (CD4+); 216.2 vs. 284.4 (CD8+); 82.6 vs. 144.1 (CD20+); 157.5 vs. 156.6 (CD68+); 150.7 vs. 166.6 (CD163+); 44.2 vs. 50.8 (FOXP3+); 53.2 vs. 70.9 (CD25+); 268.7 vs. 304.9 (GATA3+) and 62.1 vs. 91.2 (T-bet+)]. Here, CD68 is linked to neoplasm.